Synergistic anticancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL) and doxorubicin using micellar polymer nanoparticles

The use of small molecule drugs in cancer chemotherapy has mostly been limited by dose-dependent toxicity and development of drug resistance resulting from repeated administrations. To overcome such problems, efforts have been made to develop drug delivery systems that can bear multiple therapeutic...

Full description

Bibliographic Details
Main Authors: Lee, A., Dhillon, S., Wang, Y., Pervaiz, Shazib, Yang, Y.
Format: Conference Paper
Published: American Chemical Society 2012
Online Access:https://www.acs.org/content/acs/en/meetings/nationalmeetings/programarchive.html
http://hdl.handle.net/20.500.11937/53417